Press releases

  • Tuesday, 03 May 2016

    Ferring Pharmaceuticals announces approval for NOCDURNA®, a new therapeutic option for the treatment of adults waking multiple times to urinate at night

    Read press release
  • Monday, 18 April 2016

    Newly created Swiss Polar Institute to launch a major Antarctic expedition

    Read press release
  • Friday, 18 March 2016

    Wake up to nocturia: The most common cause of disrupted sleep that could be damaging your health

    Read press release
  • Monday, 07 March 2016

    Ferring Pharmaceuticals opens Asia Pacific headquarters in Singapore

    Read press release
Archive:

Helen Gallagher

Senior Director
Corporate Communications
Tel: +41 58 301 00 51

Nicole
Barraud-Estoppey

Senior Manager
Corporate Communications
Tel: +41 58 301 00 53

Corporate Communications

Ferring International Center S.A.
Ch. de la Vergognausaz 50
CH-1162 Saint-Prex
Switzerland
Tel: +41 58 301 00 00
Fax: +41 58 301 00 10


Email for media enquiries only.
For other queries, please see our Contact page.

Headquarters

Ferring International Center S.A.
Ch. de la Vergognausaz 50
1162 Saint-Prex
Switzerland

Tel:  +41 58 301 00 00
Fax: +41 58 301 00 10

Contact

GLOBAL LOCATOR